Stocks in news today
!OneSource Speciality Pharma has received Saudi Food and Drug Authority (SFDA) approval of its generic Ozempic (semaglutide) in Saudi Arabia, clearing the path for commercialising the product with Hikma Pharmaceuticals PLC(Hikma) as their exclusive commercialisation partner for the Middle East and North Africa (MENA).
!STL Networks has received Purchase Order from National Informatics Centre Services Incorporated for Procurement of network equipment through NKN. Broad commercial consideration or size of the order(s)/contract(s) is Rs 206.49 crore (Inclusive of taxes).

















